Teresa Caballero-Velazquez

Profesor Contratado Doctor Vinculada

Universidad de Sevilla

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Teresa Caballero-Velazquez is a Profesor Contratado Doctor Vinculada at Universidad de Sevilla, Spain. Her research focuses on hematological malignancies, particularly in the areas of allo-SCT, chronic graft-versus-host disease, and leukemia therapy. Her recent articles include studies on monocytosis as a prognostic factor, the effects of cannabinoids on leukemic cells, and the impact of measurable residual disease on patient outcomes in acute myeloid leukemia.

Articles (20)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Catherine Lee

Associate Professor

Fred Hutch Cancer Center

UNITED STATES

View details

Rosario M. Morales‐Camacho

SPAIN

View details

JAIME PEREZ DE OTEYZA

HEAD

SPAIN

View details

María-Belén Vidriales

Universidad de Salamanca

SPAIN

View details

Javier Briones Meijide

Professor

University of Barcelona

SPAIN

View details

José Antonio Pérez-Simón

Universidad de Sevilla

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Teresa Caballero-Velazquez

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Frontline allo-SCT in MRD-negative, intermediate-risk AML

Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkers.

Monocytosis as prognostic factor for chronic graft versus host disease

Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions

Hematological Neoplasms with Eosinophilia

Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials

Prognostic Value of Measurable Residual Disease in Patients with AML Undergoing HSCT: A Multicenter Study

Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring

Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies

Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice

Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment.

The incidental detection of clonal haemopoiesis of indeterminate potential with del(5q).

Multiple erythrophagocytosis by erythroid blasts in acute myeloid leukemia with BCR-ABL1.

Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib

Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host disease

Auer rod-like inclusions in cerebrospinal fluid in accelerated phase chronic lymphocytic leukaemia.

Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia.

High-Dimensional Analysis of Single-Cell Flow Cytometry Data Predicts Relapse in Childhood Acute Lymphoblastic Leukaemia

ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.

Collaborators (6)

Catherine Lee

Rosario M. Morales‐Camacho

JAIME PEREZ DE OTEYZA

María-Belén Vidriales

Javier Briones Meijide

José Antonio Pérez-Simón

Make your next move.